|

MC-1-50 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd2

Indications

  • Systemic Lupus Erythematosus (SLE)1
  • Refractory1
  • Lupus1
  • Non-hodgkin Lymphoma1
  • B Cell Lymphoma1

Other2 trials

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Phase 1
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.